Found: 6
Select item for more details and to access through your institution.
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
- Published in:
- Journal of Cellular Biochemistry, 2013, v. 114, n. 7, p. 1464, doi. 10.1002/jcb.24488
- By:
- Publication type:
- Article
CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo.
- Published in:
- Journal of Ovarian Research, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13048-019-0593-2
- By:
- Publication type:
- Article
[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1.
- Published in:
- Oncology Letters, 2019, v. 18, n. 4, p. 3792, doi. 10.3892/ol.2019.10694
- By:
- Publication type:
- Article